Movement Disorders · 2009 · 85 citations · 66 references
Life SciencesNeurologyNeuroscienceNeurobiology Of DiseaseNeurochemistryNeurodegenerationMolecular Basis Of NeurodegenerationNeurodegeneration MechanismsNeurodegenerative DiseasesNeurodegenerative DisordersParkinson DiseaseParkinsonian DisordersAlpha-synuclein AggregationDopaminergic NeurodegenerationNeuroinflammation In Parkinson DiseaseOxidative Stress InflammationOxidative Stress InjuryParkinson Disease PathologyParkinson's Disease ModelsParkinsonian Degeneration
The recent knowledge that 10 years after transplantation surviving human fetal neurons adopt the histopathology of Parkinson's disease suggests that Lewy body formation takes a decade to achieve. To determine whether similar histopathology occurs in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-primate models over a similar timeframe, the brains of two adult monkeys made parkinsonian in their youth with intermittent injections of MPTP were studied. Despite substantial nigral degeneration and increased alpha-synuclein immunoreactivity within surviving neurons, there was no evidence of Lewy body formation. This suggests that MPTP-induced oxidative stress and inflammation per se are not sufficient for Lewy body formation, or Lewy bodies are human specific.
66
Margaret M. Hoehn, Melvin D. Yahr · Neurology · 1967 · 12K citations · Full text
DOUBLE-BLIND STUDY OF BOTULINUM TOXIN IN SPASMODIC TORTICOLLIS
JosephK.C Tsui, A. Jon Stoessl, Andrew Eisen et al. · The Lancet · 1986 · 810 citations
Phenotype, diagnosis, and treatment of Gaucher's disease
Gregory A. Grabowski · The Lancet · 2008 · 635 citations
Dementia and survival in Parkinson disease
Tirza C. E. Buter, Ardo van den Hout, Fiona E. Matthews et al. · Neurology · 2008 · 450 citations · Full text